TriVascular Technologies, Inc. Announces FDA Approval of Ovation iX(TM) Iliac Stent Graft

By: via Benzinga
TriVascular Technologies, Inc. (Nasdaq: TRIV) announced today that theU.S. Food and Drug Administration(FDA) has approved ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.